Lisa Anson, CEO, Redx PharmaLisa Anson, CEO, Redx Pharma

$125m financing to see Macclesfield’s Redx list on Nasdaq

Firm targeting Crohn’s disease agrees financing deal and combination with Skye Bioscience which will see it rebrand and funded into 2029

Ed Rimmer, CEO, Time Finance plcEd Rimmer, CEO, Time Finance plc

£55m deal to take Time Finance private after 20 years

Mindgard foundersMindgard founders

Lancaster Uni spinout Mindgard raises another £22m

Insights

View All
businessBite

Subscribe to our newsletter

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.